AAAAAA

   
Results: 1-18 |
Results: 18
Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention
Authors: Ingle, JN
Citation: Jn. Ingle, Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention, ONCOLOGY-NY, 15(5), 2001, pp. 28-34
Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer
Authors: Porrata, LF Ingle, JN Litzow, MR Geyer, S Markovic, SN
Citation: Lf. Porrata et al., Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer, BONE MAR TR, 28(9), 2001, pp. 865-871
Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors
Authors: Wu, GJ Sinclair, C Hinson, S Ingle, JN Roche, PC Couch, FJ
Citation: Gj. Wu et al., Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors, CANCER RES, 61(13), 2001, pp. 4951-4955
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
Authors: Hillner, BE Ingle, JN Berenson, JR Janjan, NA Albain, KS Lipton, A Yee, G Biermann, JS Chlebowski, RT Pfister, DG
Citation: Be. Hillner et al., American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer, J CL ONCOL, 18(6), 2000, pp. 1378-1391
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.
Authors: Stadtmauer, EA O'Neill, A Goldstein, LJ Crilley, PA Mangan, KF Ingle, JN Brodsky, I Martino, S Lazarus, HM Erban, JK Sickles, C Glick, JH
Citation: Ea. Stadtmauer et al., Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer., N ENG J MED, 342(15), 2000, pp. 1069-1076
Bisphosphonates directly regulate cell proliferation, differentiation, andgene expression in human osteoblasts
Authors: Reinholz, GG Getz, B Pederson, L Sanders, ES Subramaniam, M Ingle, JN Spelsberg, TC
Citation: Gg. Reinholz et al., Bisphosphonates directly regulate cell proliferation, differentiation, andgene expression in human osteoblasts, CANCER RES, 60(21), 2000, pp. 6001-6007
17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGMA1B genes
Authors: Wu, GJ Sinclair, CS Paape, J Ingle, JN Roche, PC James, CD Couch, FJ
Citation: Gj. Wu et al., 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGMA1B genes, CANCER RES, 60(19), 2000, pp. 5371-5375
Multicultural aspects of breast cancer etiology workshop - Concluding comments
Authors: Ingle, JN
Citation: Jn. Ingle, Multicultural aspects of breast cancer etiology workshop - Concluding comments, CANCER, 88(5), 2000, pp. 1265-1266
A phase II study of paclitaxel plus carboplatin as first-line chemotherapyfor women with metastatic breast carcinoma
Authors: Perez, EA Hillman, DW Stella, PJ Krook, JE Hartmann, LC Fitch, TR Hatfield, AK Mailliard, JA Nair, S Kardinal, CG Ingle, JN
Citation: Ea. Perez et al., A phase II study of paclitaxel plus carboplatin as first-line chemotherapyfor women with metastatic breast carcinoma, CANCER, 88(1), 2000, pp. 124-131
External radiation exposure and mortality in a cohort of uranium processing workers
Authors: Dupree-Ellis, E Watkins, J Ingle, JN Phillips, J
Citation: E. Dupree-ellis et al., External radiation exposure and mortality in a cohort of uranium processing workers, AM J EPIDEM, 152(1), 2000, pp. 91-95
Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer
Authors: Ingle, JN Suman, VJ Jordan, VC Dowsett, M
Citation: Jn. Ingle et al., Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer, ENDOCR-R CA, 6(2), 1999, pp. 265-269
Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer
Authors: Ingle, JN Suman, VJ Johnson, PA Krook, JE Mailliard, JA Wheeler, RH Loprinzi, CL Perez, EA Jordan, VC Dowsett, M
Citation: Jn. Ingle et al., Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer, CLIN CANC R, 5(7), 1999, pp. 1642-1649
Metaplastic breast cancer: Prognosis and response to systemic therapy
Authors: Rayson, D Adjei, AA Suman, VJ Wold, LE Ingle, JN
Citation: D. Rayson et al., Metaplastic breast cancer: Prognosis and response to systemic therapy, ANN ONCOL, 10(4), 1999, pp. 413-419
The HercepTest assay: Another perspective - In reply
Authors: Roche, PC Ingle, JN
Citation: Pc. Roche et Jn. Ingle, The HercepTest assay: Another perspective - In reply, J CL ONCOL, 17(7), 1999, pp. 2294-2294
Increased HER2 with US Food and Drug Administration-approved antibody
Authors: Roche, PC Ingle, JN
Citation: Pc. Roche et Jn. Ingle, Increased HER2 with US Food and Drug Administration-approved antibody, J CL ONCOL, 17(1), 1999, pp. 434-434
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis
Authors: Peethambaram, PP Ingle, JN Suman, VJ Hartmann, LC Loprinzi, CL
Citation: Pp. Peethambaram et al., Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis, BREAST CANC, 54(2), 1999, pp. 117-122
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas
Authors: Rajkumar, SV Buckner, JC Schomberg, PJ Pitot, HC Ingle, JN Cascino, TL
Citation: Sv. Rajkumar et al., Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas, NEUROSURGER, 44(1), 1999, pp. 67-73
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma
Authors: Ingle, JN Suman, VJ Kardinal, CG Krook, JE Mailliard, JA Veeder, MH Loprinzi, CL Dalton, RJ Hartmann, LC Conover, CA Pollak, MN
Citation: Jn. Ingle et al., A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma, CANCER, 85(6), 1999, pp. 1284-1292
Risultati: 1-18 |